Literature DB >> 8508624

Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee.

K Piwernetz, P D Home, O Snorgaard, M Antsiferov, K Staehr-Johansen, M Krans.   

Abstract

The St Vincent Declaration, a joint initiative on diabetes care and research of the World Health Organization (Europe) and the International Diabetes Federation (Europe), includes 5-year targets for improvement in diabetes outcomes as a central tenet. Accordingly, the establishment of state of the art monitoring and control systems is urged as a basis for the implementation of quality management. As a prerequisite for both targets, a diabetes dataset (fields and definitions) has been agreed to allow common monitoring of diabetes throughout Europe. This dataset has been further developed as the foundation stone of DiabCare, an initiative for continuous quality development in diabetes care. In a formal consensus process using the Delphi method, over 130 European diabetologists from 21 countries contributed to the development of this dataset, which includes fields covering true patient outcomes, intermediate metabolic outcomes, markers of diabetes tissue damage, risk factors, pregnancy, and life-style. The tools for documentation of the quality of health status have been developed in three formats for use in different health care settings. These tools, the DiabCare Diabetes Dataset, the DiabCare Basic Information Sheet, and the DiabCare Computer Program, are designed to allow local feedback-driven improvement in the quality of care, but are also the subject of communication protocols to compare performance between centres, regions, and countries. Whether implemented with or without the benefits of modern information technology, these initiatives can be the basis for both monitoring the targets of the St Vincent Declaration and for implementation of continuing quality development in diabetes care.

Entities:  

Mesh:

Year:  1993        PMID: 8508624     DOI: 10.1111/j.1464-5491.1993.tb00083.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  42 in total

1.  Cost implications of wastage of drugs: focus on insulin.

Authors:  B Costa; M Belmonte
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

2.  End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry.

Authors:  X L Yang; W Y So; A P S Kong; P Clarke; C S Ho; C W K Lam; M H L Ng; R R Lyu; D D Yin; C C Chow; C S Cockram; P C Y Tong; J C N Chan
Journal:  Diabetologia       Date:  2006-08-30       Impact factor: 10.122

3.  Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients.

Authors:  A Y S Cheng; A P S Kong; V W S Wong; W Y So; H L Y Chan; C S Ho; C W K Lam; J S Tam; C C Chow; C S Cockram; J C N Chan; P C Y Tong
Journal:  Diabetologia       Date:  2006-05-31       Impact factor: 10.122

Review 4.  Pharmacoeconomics of diabetes surveillance and detection programmes.

Authors:  P D Home
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

Review 5.  Diabetes mellitus and the St Vincent Declaration. The economic implications.

Authors:  B Leese
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

6.  Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Authors:  Xilin Yang; Wing Yee So; Ronald C W Ma; Gary T C Ko; Alice P S Kong; Hailu Zhao; Andrea O Y Luk; Christopher W K Lam; Chung Shun Ho; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 19.112

7.  Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Authors:  Xilin Yang; Gary T C Ko; Wing Yee So; Ronald C W Ma; Linda W L Yu; Alice P S Kong; Hailu Zhao; Chun-Chung Chow; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

8.  Diabetes care in general practice: an approach to audit of process and outcome.

Authors:  F K Tunbridge; J P Millar; P J Schofield; J A Spencer; G Young; P D Home
Journal:  Br J Gen Pract       Date:  1993-07       Impact factor: 5.386

9.  Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients--a longitudinal observational study.

Authors:  Wilson Y Leung; Wing-yee So; Derek Stewart; Augustine Lui; Peter C Tong; Gary T Ko; Alice P Kong; Ronald C Ma; Francis K Chan; Xilin Yang; Sau-chu Chiang; Juliana C Chan
Journal:  Cardiovasc Diabetol       Date:  2009-10-30       Impact factor: 9.951

10.  Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes.

Authors:  Xilin Yang; Hailu Zhao; Yi Sui; Ronald C W Ma; Wing Yee So; Gary T C Ko; Alice P S Kong; Risa Ozaki; Chun Yip Yeung; Gang Xu; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.